Si-bone share price today

(SIBN)

Si-bone share price is $14.12 & ₹1,211.64 as on 7 Jan 2025, 2.30 'hrs' IST

$14.12

▲

-0.15

(-1.05%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Si-bone share price in Dollar and Rupees. Guide to invest in Si-bone stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Si-bone, along with analyst recommendations, forecasts, and comprehensive financials.

Si-bone share price movements

Today's Low: $14.03
Today's High: $14.45
$14.12
0.64%
Downside
Day's Volatility :2.91%
Upside
2.28%
52 Weeks Low: $11.70
52 Weeks High: $21.64
$14.12
17.14%
Downside
52 Weeks Volatility :45.93%
Upside
34.75%

Si-bone Returns

Period	Si-bone Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	6.1%	-8.4%	0.0%
6 Months	6.1%	-3.8%	0.0%
1 Year	-26.25%	-0.1%	0.0%
3 Years	-37.33%	2.9%	-19.8%

Si-bone Key Statistics

in dollars & INR

Previous Close	$14.27
Open	$14.3
Today's High	$14.45
Today's Low	$14.03
Market Capitalization	$588.0M
Today's Volume	$243.2K
52 Week High	$21.64
52 Week Low	$11.7
Revenue TTM	$157.0M
EBITDA	$-37.5M
Earnings Per Share (EPS)	$-0.91
Profit Margin	-23.82%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-22.09%

How to invest in Si-bone from India?

It is very easy for Indian residents to invest directly in Si-bone from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Si-bone stock in both Indian Rupees (INR) and US Dollars (USD). Search for Si-bone or SIBN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Si-bone or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Si-bone shares which would translate to 0.061 fractional shares of Si-bone as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Si-bone, in just a few clicks!

Returns in Si-bone for Indian investors in Rupees

Investment Value

₹1,00,000

Si-bone investment value today

Current value as on today

₹76,194

Returns

₹23,806

(-23.81%)

Returns from Si-bone Stock

₹27,028 (-27.03%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Si-bone

-25%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Si-bone on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -25% less investors are searching Si-bone in the last 30 days versus the previous period.

Global Institutional Holdings in Si-bone

Brown Advisory Holdings Inc
9.55%
BlackRock Inc
9.17%
Orbimed Advisors, LLC
7.88%
Champlain Investment Partners, LLC
6.68%
Vanguard Group Inc
5.77%
American Century Companies Inc
5.11%

Analyst Recommendation on Si-bone

Buy

93%Buy

6%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Si-bone(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Si-bone

What analysts predicted

Upside of 61.32%

Current:

$14.12

Target:

$22.78

Insights on Si-bone

Price Movement
In the last 1 month, SIBN stock has moved up by 5.5%
Increasing Revenue
Revenue is up for the last 3 quarters, 37.86M → 40.34M (in $), with an average increase of 3.1% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -10.98M → -6.57M (in $), with an average increase of 19.6% per quarter
SIBN vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 55.9% return, outperforming this stock by 87.4%
SIBN vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 112.9% return, outperforming this stock by 149.2%
Price to Sales
ForSIBN every $1 of sales, investors are willing to pay $3.7, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Si-bone Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$55.4M	↑ 15.42%
Net Income	$-17.5M	↓ 24.25%
Net Profit Margin	-31.51%	↑ 16.5%

	FY19	Y/Y Change
Revenue	$67.3M	↑ 21.53%
Net Income	$-42.6M	↑ 143.95%
Net Profit Margin	-63.26%	↓ 31.75%

	FY20	Y/Y Change
Revenue	$73.4M	↑ 9.04%
Net Income	$-48.5M	↑ 14.01%
Net Profit Margin	-66.15%	↓ 2.89%

	FY21	Y/Y Change
Revenue	$90.2M	↑ 22.84%
Net Income	$-60.1M	↑ 23.87%
Net Profit Margin	-66.7%	↓ 0.55%

	FY22	Y/Y Change
Revenue	$106.4M	↑ 18.03%
Net Income	$-62.9M	↑ 4.62%
Net Profit Margin	-59.11%	↑ 7.59%

	FY23	Y/Y Change
Revenue	$138.9M	↑ 30.52%
Net Income	$-43.3M	↓ 31.11%
Net Profit Margin	-31.2%	↑ 27.91%

	Q2 FY23	Q/Q Change
Revenue	$33.3M	↑ 1.83%
Net Income	$-11.2M	↑ 10.74%
Net Profit Margin	-33.65%	↓ 2.71%

	Q3 FY23	Q/Q Change
Revenue	$34.0M	↑ 2.13%
Net Income	$-10.0M	↓ 10.57%
Net Profit Margin	-29.46%	↑ 4.19%

	Q4 FY23	Q/Q Change
Revenue	$38.9M	↑ 14.24%
Net Income	$-11.0M	↑ 9.59%
Net Profit Margin	-28.26%	↑ 1.2%

	Q1 FY24	Q/Q Change
Revenue	$37.9M	↓ 2.55%
Net Income	$-10.9M	↓ 0.72%
Net Profit Margin	-28.8%	↓ 0.54%

	Q2 FY24	Q/Q Change
Revenue	$40.0M	↑ 5.55%
Net Income	$-8.9M	↓ 18.02%
Net Profit Margin	-22.36%	↑ 6.44%

	Q3 FY24	Q/Q Change
Revenue	$40.3M	↑ 0.93%
Net Income	$-6.6M	↓ 26.45%
Net Profit Margin	-16.3%	↑ 6.06%

	FY18	Y/Y Change
Profit	$50.5M	↑ 17.9%

	FY19	Y/Y Change
Profit	$60.5M	↑ 19.71%

	FY20	Y/Y Change
Profit	$64.5M	↑ 6.57%

	FY21	Y/Y Change
Profit	$79.7M	↑ 23.63%

	FY22	Y/Y Change
Profit	$90.7M	↑ 13.77%

	FY23	Y/Y Change
Profit	$109.4M	↑ 20.63%

	Q2 FY23	Q/Q Change
Profit	$27.0M	↑ 0.76%

	Q3 FY23	Q/Q Change
Profit	$27.0M	↓ 0.05%

	Q4 FY23	Q/Q Change
Profit	$28.7M	↑ 6.31%

	Q1 FY24	Q/Q Change
Profit	$29.9M	↑ 4.15%

	Q2 FY24	Q/Q Change
Profit	$31.6M	↑ 5.73%

	Q3 FY24	Q/Q Change
Profit	$31.9M	↑ 1.04%

	FY18	Y/Y Change
Operating Cash Flow	$-14.5M	↓ 17.18%
Investing Cash Flow	$-97.8M	↑ 20365.48%
Financing Cash Flow	$115.2M	↑ 795.27%

	FY19	Y/Y Change
Operating Cash Flow	$-31.6M	↑ 117.83%
Investing Cash Flow	$13.5M	↓ 113.79%
Financing Cash Flow	$3.5M	↓ 96.97%

	FY20	Y/Y Change
Operating Cash Flow	$-30.7M	↓ 3.05%
Investing Cash Flow	$-62.9M	↓ 566.36%
Financing Cash Flow	$136.4M	↑ 3810.58%

	FY21	Y/Y Change
Operating Cash Flow	$-39.5M	↑ 28.93%
Investing Cash Flow	$51.6M	↓ 181.98%
Financing Cash Flow	$-1.7M	↓ 101.25%

	FY22	Y/Y Change
Operating Cash Flow	$-41.7M	↑ 5.37%
Investing Cash Flow	$-2.8M	↓ 105.46%
Financing Cash Flow	$2.2M	↓ 228.4%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-3.6M	↓ 66.61%
Investing Cash Flow	$2.3M	↓ 80.51%
Financing Cash Flow	$89.1M	↑ 7296.1%

Si-bone Technicals Summary

Sell

Neutral

Buy

Si-bone is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Si-bone Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Si-bone Inc	5.0%	6.1%	-26.25%	-37.33%	-34.96%
Stryker Corporation	-5.14%	7.73%	20.51%	37.02%	70.83%
Boston Scientific Corp.	2.22%	18.53%	55.24%	113.84%	98.4%
Edwards Lifesciences Corp.	4.25%	-20.93%	-2.33%	-38.47%	-5.21%
Abbott Laboratories	-0.93%	11.99%	1.27%	-15.84%	31.69%
Medtronic Plc	-3.59%	5.29%	-6.49%	-23.36%	-31.62%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Si-bone Inc	NA	NA	NA	-0.78	-0.22	-0.12	NA	3.95
Stryker Corporation	38.59	38.59	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.82	73.82	1.62	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.0	28.0	6.67	2.54	0.19	0.11	NA	16.18
Abbott Laboratories	34.38	34.38	2.19	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.43	24.43	1.46	5.45	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Si-bone Inc	Buy	$588.0M	-34.96%	NA	-23.82%
Stryker Corporation	Buy	$137.3B	70.83%	38.59	16.34%
Boston Scientific Corp.	Buy	$131.6B	98.4%	73.82	11.26%
Edwards Lifesciences Corp.	Buy	$43.6B	-5.21%	28.0	65.86%
Abbott Laboratories	Buy	$196.2B	31.69%	34.38	13.99%
Medtronic Plc	Buy	$102.4B	-31.62%	24.43	12.06%

About Si-bone

si-bone® is focused on helping patients in one of the most under-served, under-diagnosed, and under-treated areas in orthopedics, the sacroiliac (si) joint. si-bone developed an innovative, patented implant to fuse the si joint. the ifuse implant system® provides a less invasive alternative to traditional sacroiliac (si) joint fusion surgery and has been used in over 25,000 procedures to date. the company is managed by an experienced team of executives from kyphon, medtronic, inbone, saint francis and several start up orthopedic and spine companies. the ifuse implant system is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. this includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. there are potential risks associated with the ifuse implant system. it may not be appropriate for al

Organization	Si-bone
Employees	344
CEO	Ms. Laura A. Francis MBA
Industry	Health Technology

Management People of Si-bone

Name	Title
Ms. Laura A. Francis MBA	CEO & Director
Mr. Anshul Maheshwari	Chief Financial Officer
Mr. Anthony J. Recupero	President of Commercial Operations
Mr. Jeff Bertolini	Senior Vice President of Operations & Information Technology
Dr. Scott A. Yerby	Senior VP of Engineering & CTO
Saqib Iqbal	Director of FP&A and Investor Relations
Mr. Michael A. Pisetsky J.D.	Chief Business & Legal Affairs Officer, Secretary and General Counsel
Ms. Aimee Einstein	Vice President of People & Culture
Dr. Daniel Joseph Cher	Senior Vice President of Clinical & Regulatory Affairs
Dr. W. Carlton Reckling	Chief Medical Officer & VP of Medical Affairs

Important FAQs about investing in Si-bone from India :

What is Si-bone share price today?

Si-bone share price today stands at $14.12, Open: $14.30 ; Previous Close: $14.27 ; High: $14.45 ; Low: $14.03 ; 52 Week High: $21.64 ; 52 Week Low: $11.70. The stock opens at $14.30, after a previous close of $14.27. The stock reached a daily high of $14.45 and a low of $14.03, with a 52-week high of $21.64 and a 52-week low of $11.70.

Can Indians buy Si-bone shares?

Yes, Indians can invest in the Si-bone (SIBN) from India.

With INDmoney, you can buy Si-bone at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Si-bone at zero transaction cost.

How can I buy Si-bone shares from India?

It is very easy to buy Si-bone from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Si-bone be purchased?

Yes, you can buy fractional shares of Si-bone with INDmoney app.

What are the documents required to start investing in Si-bone stocks?

To start investing in Si-bone, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Si-bone

Today’s highest price of Si-bone (SIBN) is $14.45.

Today’s lowest price of Si-bone (SIBN) is $14.03.

What is today's market capitalisation of Si-bone

Today's market capitalisation of Si-bone SIBN is 588.0M

What is the 52 Week High and Low Range of Si-bone

52 Week High
$21.64
52 Week Low
$11.70

What are the historical returns of Si-bone?

1 Month Returns
5%
3 Months Returns
6.1%
1 Year Returns
-26.25%
5 Years Returns
-34.96%

Who is the Chief Executive Officer (CEO) of Si-bone

Ms. Laura A. Francis MBA is the current Chief Executive Officer (CEO) of Si-bone.

Discover More

Explore all